Press release: Qaelum completes € 2 Mio internal investment round to support global growth
August 30, 2016
Qaelum N.V., the Belgium-based international specialist in medical quality monitoring and analysis, announces it has completed an internal capital round of € 2 Mio. The capital is provided by Qaelum’s current investors – including Gemma Frisius Fund KU Leuven and business angel Marc Beuls – extended with Dr. Jan Schillebeeckx, the current CMO of the company. The Qaelum team will use the investment to further strengthen the management & sales structure and expand overseas. Qaelum is a spin-off of the University Hospitals Leuven. Today, this link is reinforced with Prof. Dr. Frank Rademakers joining Qaelum’s Board of Directors.
Showing confidence in the momentum of Qaelum’
Qaelum has grown fast since 2012, when it spun out from the University Hospitals Leuven, Belgium. In only four years, Qaelum successively launched its total quality monitoring solutions (DOSE, QBOOK, BASELINE, etc.). Qaelum’s integrated software suite monitors, analyses and improves a range of quality aspects related to patient radiation dose. In addition, it guarantees maximum safety of patients and staff in medical imaging departments. Other milestones are the agreements with FUJIFILM and AGFA Healthcare to operate as Qaelum distributors with sales teams promoting and selling DOSE internationally.
Luc Vandenbroucke, Chairman of Qaelum Board of Directors: “Today Qaelum announces a new milestone with an internal € 2 Mio investment round. I welcome the additional funds as a token of confidence the present shareholders show in the future of Qaelum. These funds will be used mainly to strengthen the management & sales structure and support the geographical expansion.”
Strengthened management team and overseas expansion
The internal investment round primarily includes funds from current shareholders Gemma Frisius Fund KU Leuven, business angel Marc Beuls and the other Qaelum shareholders – extended with Dr. Jan Schillebeeckx, CMO of the company since 2013. Dr. Schillebeeckx is a key opinion leader in the field of medical imaging and a European pioneer in PACS and Teleradiology. He is also stakeholder for eHealth at the European Commission. Earlier on he headed the medical imaging department at the Imelda Hospital (Bonheiden, Belgium) for 23 years.
Qaelum welcomes Prof. Dr. Frank Rademakers as a new member of its Board of Directors. This appointment illustrates the strengthened collaboration with the University Hospitals Leuven, from which Qaelum originally has spun out from.
CEO Jurgen Jacobs: “I see the internal investment round as a confirmation of the exceptional achievements realised by the entire Qaelum team. The investors support our business strategy for the coming years. We will extend our management team and strengthen our sales force. We are going to increase local presence in key EMEA regions and start gaining foothold in hospitals outside Europe and Middle East. In general, we sense a growing awareness of medical radiation and associated risks. Furthermore, medical imaging departments need to adhere to a number of accreditation and auditing obligations. Our unique offering converts the burden of lengthy manual quality evaluations into a valuable tool for continuous quality improvement. After obtaining CE class IIb classification for the EU market, Qaelum software has now also been approved for use in the US and Canada.”
Communication de presse en Français
Comunicado de prensa en español
About Qaelum
Qaelum is a high-tech spin-off company of the University Hospitals Leuven. Based on more than 15 years of quality assurance experience in an academic environment as well as in the field, QAELUM is seen as the preferred partner when it comes to medical imaging quality control. Leading hospital groups share our vision of a global system for quality assurance, which realises optimal use of radiation and guarantees maximum safety for patients and staff. At the same time, they acquire a more detailed overview of and deeper insights into all quality related aspects.
Passionate about solving real world problems, Qaelum focuses on the development and deployment of highly innovative solutions and services to resolve the daily problems of every medical imaging professional. Ranging from automated quality control in nationwide breast screening programs to optimised solutions for local patient dose monitoring, Qaelum has solutions for all these problems regardless of the scale. The combination of advanced software tools and expert knowledge in the field, makes the innovative solutions offering a preferred choice for healthcare professionals.
Contact persons
Jurgen Jacobs
CEO
Email:
Mobile: +32 472 801293
Rob Snoeijs
Marketing Communication
Email:
Mobile: +32 499 331414
QAELUM N.V.
Innovation and Incubation Centre KU Leuven (I&I)
Kapeldreef 60, 3001 Leuven, Belgium
Website: www.qaelum.com
Phone: +32 16 298338
Email:
Fax: +32 16 298319
